Site Logo

Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.

Interested in a Clinical Study?

We’re currently enrolling participants for the Valo Study, a Phase 2/3 multicenter clinical study evaluating the safety and efficacy of PTX-022 (QTORIN rapamcin) in adults with moderate to severe Pachyonychia Congenita (PC). The trial will require up to 6 clinic visits and includes travel assistance if required.

Clinical Study Requirements:
  • Moderate-to-Severe PC
  • Adults, Age 18 or older
  • Able and willing to comply with all protocol-required activities